Analysis of risk factors affecting the prognosis of pancreatic neuroendocrine tumors

被引:0
|
作者
Tao Ming [1 ]
Yuan Chunhui [1 ]
Xiu Dianrong [1 ]
Shi Xueying [2 ]
Tao Liyuan [3 ]
Ma Zhaolai [1 ]
Jiang Bin [1 ]
Zhang Zhipeng [1 ]
Zhang Lingfu [1 ]
Wang Hangyan [1 ]
机构
[1] Department of General Surgery, Peking University Third Hospital
[2] Department of Pathology, Peking University Health Science Center
[3] Peking University Third Hospital Research Center of Clinical Epidemiology
关键词
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
Background Pancreatic neuroendocrine tumors(p NETs) are a type of tumors with the characteristics of easy metastasis and recurrence. Till date, the risk factors affecting the prognosis are still in the debate. In this study, several risk factors will be discussed combined with our cases and experience.Methods Thirty-three patients diagnosed as p NETs were enrolled and the clinical features, blood tests, pathological features, surgical treatment, and follow-up data of these patients were collected and analyzed.Results In this study, operation time of G3 cases was longer than G1/G2 cases(P=0.017). The elevated level of tumor markers such as AFP, CEA, Ca125, and Ca19-9 may predict easier metastasis, earlier recurrence, and poor prognosis(P=0.007). The presence of cancer embolus and nerve invasion increases along with the TNM stage(P=0.037 and P=0.040), and the incidence of positive surgical margin increased(P=0.007). When the presence of nerve invasion occurs, the chance of cancer embolus and lymph node metastasis also increases(P=0.016 and P=0.026).Conclusions p NETs were tumors with the features of easy recurrence and metastasis and many risk factors could affect its prognosis such as the elevated levels of tumor markers and the presence of nerve invasion, except some recognized risk factors. If one or more of these factors existed, postoperative treatments may be needed to improve prognosis.
引用
收藏
页码:2924 / 2928
相关论文
共 50 条
  • [1] Analysis of risk factors affecting the prognosis of pancreatic neuroendocrine tumors
    Tao Ming
    Yuan Chunhui
    Xiu Dianrong
    Shi Xueying
    Tao Liyuan
    Ma Zhaolai
    Jiang Bin
    Zhang Zhipeng
    Zhang Lingfu
    Wang Hangyan
    CHINESE MEDICAL JOURNAL, 2014, 127 (16) : 2924 - 2928
  • [2] Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors
    Li, Peng
    Wu, Fan
    Zhao, Hong
    Dou, Lizhou
    Wang, Yang
    Guo, Chunguang
    Wang, Guiqi
    Zhao, Dongbing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 13331 - 13338
  • [3] Biomarkers for prognosis in pancreatic neuroendocrine tumors
    Zhu, Mojun
    Sorenson, Karl R.
    Liu, Rebecca
    Rothberg, Bonnie E. Gould
    Halfdanarson, Thorvardur R.
    ENDOCRINE-RELATED CANCER, 2021, 28 (12) : 773 - 782
  • [4] Neuroendocrine Pancreatic Tumors Are Risk Factors for Pancreatic Fistula after Pancreatic Surgery
    Fendrich, Volker
    Merz, Marianne K.
    Waldmann, Jens
    Langer, Peter
    Heverhagen, Anna E.
    Dietzel, Kristin
    Bartsch, Detlef K.
    DIGESTIVE SURGERY, 2011, 28 (04) : 263 - 269
  • [5] Risk factors for complications after surgery for pancreatic neuroendocrine tumors
    van Beek, Dirk-Jan
    Takkenkamp, Tim J.
    Wong-Lun-Hing, Edgar M.
    Kleine, Ruben H. J. de
    Walenkamp, Annemiek M. E.
    Klaase, Joost M.
    Nijkamp, Maarten W.
    Valk, Gerlof D.
    Molenaar, I. Quintus
    Hagendoorn, Jeroen
    Santvoort, Hjalmar C. van
    Rinkes, Inne H. M. Borel
    Hoogwater, Frederik J. H.
    Vriens, Menno R.
    SURGERY, 2022, 172 (01) : 127 - 136
  • [6] Risk factors for complications after surgery for pancreatic neuroendocrine tumors
    van Beek, D. J.
    Takkenkamp, T.
    de Kleine, R.
    Walenkamp, A.
    Klaase, J.
    Nijkamp, M.
    Valk, G. D.
    Molenaar, I. Q.
    Hagendoorn, J.
    Rinkes, Borel, I
    Hoogwater, F.
    Vriens, M.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 208 - 208
  • [7] Immunohistochemical Markers and Prognosis with Pancreatic Neuroendocrine Tumors
    Zhao, Z.
    Mentrikoski, M. J.
    Bauer, T. W.
    Lindberg, J. M.
    Stelow, E. B.
    LABORATORY INVESTIGATION, 2014, 94 : 458A - 458A
  • [8] Immunohistochemical Markers and Prognosis with Pancreatic Neuroendocrine Tumors
    Zhao, Z.
    Mentrikoski, M. J.
    Bauer, T. W.
    Lindberg, J. M.
    Stelow, E. B.
    MODERN PATHOLOGY, 2014, 27 : 458A - 458A
  • [9] Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
    Mei, Wentong
    Cao, Feng
    Lu, Jiongdi
    Qu, Chang
    Fang, Zhen
    Li, Jia
    Li, Fei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [10] MALIGNANT TUMORS OF TONSIL - ANALYSIS OF FAILURES AND FACTORS AFFECTING PROGNOSIS
    PEREZ, CA
    ACKERMAN, LV
    MILL, WB
    POWERS, WE
    OGURA, JH
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1972, 114 (01) : 43 - &